Odonate Therapeutics, Inc. (ODTC)

OTCMKTS: ODTC · Delayed Price · USD
1.45
-0.06 (-3.97%)
May 24, 2022 4:00 PM - Market closed
Market Cap55.81M
Revenue (ttm)n/a
Net Income (ttm)-102.07M
Shares Out38.49M
EPS (ttm)-2.71
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume72,306
Open1.46
Previous Close1.51
Day's Range1.45 - 1.55
52-Week Range0.82 - 4.13
Beta0.42
AnalystsSell
Price Target4.08 (+181.4%)
Earnings DateFeb 21, 2022

About ODTC

Odonate Therapeutics, Inc., a pharmaceutical company, develops therapeutics for the treatment of cancer. It is developing tesetaxel, an orally administered chemotherapy agent, which is in Phase III clinical study for patients with metastatic breast cancer. The company was founded in 2013 and is based in New York, New York.

IndustryBiotechnology
IPO DateDec 7, 2017
Employees137
Stock ExchangeOTCMKTS
Ticker SymbolODTC
Full Company Profile

Financial Performance

Financial Statements

Analyst Forecast

According to 7 analysts, the average rating for ODTC stock is "Sell." The 12-month stock price forecast is 4.08, which is an increase of 181.38% from the latest price.

Price Target
$4.08
(181.38% upside)
Analyst Consensus: Sell
Stock Forecasts

News

Grabar Law Office Investigates Potential Claims Against Officers and Directors of Odonate Therapeutics, Inc. After an...

Philadelphia, Pennsylvania--(Newsfile Corp. - May 10, 2022) - Odonate Therapeutics Inc. (NASDAQ: ODT) (OTC Pink: ODTC) has agreed to pay $12.5 million to resolve a proposed securities class action in al...

2 weeks ago - Newsfile Corp

Odonate Announces Expected Delisting of Its Stock

NEW YORK--(BUSINESS WIRE)--Odonate Therapeutics, Inc. (NASDAQ: ODT) today announced that on January 6, 2022 it received written notice from The Nasdaq Stock Market LLC (“Nasdaq”) notifying Odonate that ...

4 months ago - Business Wire

Odonate Therapeutics Announces Planned Return of Capital to Stockholders through Share Repurchase Plan

NEW YORK--(BUSINESS WIRE)--Odonate Therapeutics, Inc. (NASDAQ: ODT) today announced that it will commence a share repurchase plan for up to 20 million shares in order to return capital to stockholders. ...

6 months ago - Business Wire

Odonate Therapeutics Announces Financial Results for the Three and Nine Months Ended September 30, 2021

NEW YORK--(BUSINESS WIRE)--Odonate Therapeutics, Inc. (NASDAQ: ODT) today announced financial results for the three and nine months ended September 30, 2021. As of September 30, 2021, Odonate had $95.0 ...

6 months ago - Business Wire

SHAREHOLDER ALERT: Odonate Therapeutics, Inc. (ODT) Officers and Directors Under Investigation for Possible False Sta...

SAN FRANCISCO, Aug. 13, 2021 /PRNewswire/ -- Schubert Jonckheer & Kolbe LLP is investigating potential derivative claims on behalf of shareholders of Odonate Therapeutics, Inc. (NASDAQ: ODT) relating to...

9 months ago - PRNewsWire

The Law Offices of Frank R. Cruz Announces Investigation of Odonate Therapeutics, Inc. (ODT) on Behalf of Investors

LOS ANGELES--(BUSINESS WIRE)---- $ODT #investors--The Law Offices of Frank R. Cruz Announces Investigation of Odonate Therapeutics, Inc. (ODT) on Behalf of Investors

9 months ago - Business Wire

Odonate Therapeutics Announces Financial Results for the Three and Six Months Ended June 30, 2021

NEW YORK--(BUSINESS WIRE)--Odonate Therapeutics, Inc. (NASDAQ: ODT) today announced financial results for the three and six months ended June 30, 2021. In March 2021, Odonate announced the discontinuati...

9 months ago - Business Wire

Why Odonate Therapeutics, Opthea, ALX Oncology, Advaxis and Provention Bio Are Moving Today

Odonate Therapeutics, Inc. (NASDAQ: ODT), Opthea Limited (NASDAQ: OPT), ALX Oncology Holdings Inc. (NASDAQ: ALXO), Provention Bio, Inc. (NASDAQ: PRVB) and Advaxis, Inc. (NASDAQ: ADXS) are among the bigg...

Other symbols:ADXSALXOPRVB
10 months ago - Benzinga

7 Penny Stocks For Your Watch List This Week If You Like Biotech In July

Looking for biotech penny stocks to watch right now? Here are 7 for your list this week.

10 months ago - PennyStocks

Odonate Therapeutics Announces Financial Results for the Three Months Ended March 31, 2021

NEW YORK--(BUSINESS WIRE)--Odonate Therapeutics, Inc. (NASDAQ: ODT) today announced financial results for the three months ended March 31, 2021. Odonate recently announced the discontinuation of develop...

1 year ago - Business Wire

Odonate Therapeutics (ODT) Enters Oversold Territory

Odonate Therapeutics (ODT) has been on a bit of a cold streak lately, but there might be light at the end of the tunnel for this overlooked stock

1 year ago - Zacks Investment Research

Odonate Therapeutics (ODT) is Oversold: Can It Recover?

Odonate Therapeutics (ODT) has been on a bit of a cold streak lately, but there might be light at the end of the tunnel for this overlooked stock.

1 year ago - Zacks Investment Research

Do Options Traders Know Something About Odonate Therapeutics (ODT) Stock We Don't?

Investors need to pay close attention to Odonate Therapeutics (ODT) stock based on the movements in the options market lately.

1 year ago - Zacks Investment Research

Why GRPN Stock And ODT Stock Are Trading Lower Today

Groupon Inc (NASDAQ: GRPN) shares are trading lower Monday after the company announced a proposed private offering of $200 million of convertible senior notes. Groupon acts as the middleman between cons...

Other symbols:GRPN
1 year ago - Benzinga

Odonate Therapeutics stock plummets toward record low after plan to 'wind down' operations

Shares of Odonate Therapeutics Inc. plummeted 79.0% in active afternoon trading Monday, after the pharmaceutical company said it will wind down operations following disappointing data from its cancer tr...

1 year ago - Market Watch

Why Odonate Therapeutics Stock Is Crashing Today

The company's news was so bad that it's going out of business.

1 year ago - The Motley Fool

Why Odonate, Marker Therapeutics and Dyadic Are Moving Monday

Odonate Therapeutics, Inc. (NASDAQ: ODT), Dyadic International, Inc. (NASDAQ: DYAI) and Marker Therapeutics, Inc. (NASDAQ: MRKR) are among the early biotech movers in Monday's session. Odonate to Shut S...

Other symbols:DYAIMRKR
1 year ago - Benzinga

Odonate Therapeutics Announces Discontinuation of Development of Tesetaxel

NEW YORK--(BUSINESS WIRE)--Following feedback from the U.S. Food and Drug Administration (FDA) in a pre-New Drug Application meeting, Odonate Therapeutics, Inc. (NASDAQ: ODT) has concluded that the clin...

1 year ago - Business Wire

Odonate Therapeutics Announces Financial Results for the Three and Twelve Months Ended December 31, 2020

NEW YORK--(BUSINESS WIRE)--Odonate Therapeutics, Inc. (NASDAQ: ODT), a pharmaceutical company dedicated to the development of best-in-class therapeutics that improve and extend the lives of patients wit...

1 year ago - Business Wire

Notable Insider Buys Of The Past Week: Danimer Scientific, Cheniere Energy Partners And More

Conventional wisdom says that insiders and 10% owners really only buy shares of a company for one reason — they believe the stock price will rise and they want to profit from it. So insider buying can b...

1 year ago - Benzinga

Notable Insider Buys In The Week Of Christmas: Foot Locker, GameStop, NetApp And More

Conventional wisdom says that insiders and 10% owners really only buy shares of a company for one reason — they believe the stock price will rise and they want to profit from it. So insider buying can b...

1 year ago - Benzinga

Positive Results of CONTESSA, a Phase 3 Study of Tesetaxel in Patients with Metastatic Breast Cancer, Presented at th...

SAN DIEGO--(BUSINESS WIRE)--Odonate Therapeutics, Inc. (NASDAQ: ODT), a pharmaceutical company dedicated to the development of best‑in‑class therapeutics that improve and extend the lives of patients wi...

1 year ago - Business Wire

Odonate Therapeutics Initiates Cohort 3 of CONTESSA TRIO to Evaluate Tesetaxel Monotherapy in Patients with Metastati...

SAN DIEGO--(BUSINESS WIRE)--Odonate Therapeutics, Inc. (NASDAQ: ODT), a pharmaceutical company dedicated to the development of best-in-class therapeutics that improve and extend the lives of patients wi...

1 year ago - Business Wire

Odonate Therapeutics to Host Virtual Investor and Analyst Event on December 11, 2020

SAN DIEGO--(BUSINESS WIRE)--Odonate Therapeutics, Inc. (NASDAQ: ODT), a pharmaceutical company dedicated to the development of best-in-class therapeutics that improve and extend the lives of patients wi...

1 year ago - Business Wire

ODT ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of November 16, 2020 in the Class Action Filed on B...

New York, New York--(Newsfile Corp. - November 16, 2020) -  The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Odonate Therapeutics, Inc. (NASDAQ: ODT...

1 year ago - Newsfile Corp